EN DE
Watch AMN Healthcare Services Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

AMN Healthcare Services Inc (AMN) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of AMN Healthcare Services Inc stock $66.90, price $36.19, upside +84.9%, quality 54 out of 100. Rating: strongly undervalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US

AH AMN Healthcare Services Inc logo Some data Nov 6, 2026

AMN Healthcare Services Inc

AMN · US
Meets all rules: undervalued, solid quality, uptrend

The stock costs 46% less than our calculation considers fair.

Fair value $66.90 · Strongly undervalued (46%)
Generates free cash flow
Upbeat coverage
Even on cautious assumptions the value is 4% above the price ($37.67).
Quality 54/100
Thin margins · 3.1% net margin (TTM)
Moderate debt
Mixed vs. peers (7/13)
Insiders sold $114,369 (6M)
Some data
Weak Growth (revenue 3y −19.5 %/yr in USD)
Narrow moat 31/100
Watch AMN Healthcare Services Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$127.04 $15.10 Fair Value $66.90 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

60‑month range $15.10 – $127.04 · fair‑value band $37.67 – $100.54 · the $36.19 price screens below the $66.90 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow AMN Healthcare Services in your weekly email

Every Wednesday you see whether AMN Healthcare Services is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.

Show moreShow less

It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions.

It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, and allied health professionals, such as skilled nursing facilities, rehabilitation clinics, schools, and pharmacies, as well as physician and advanced practice staffing, and revenue cycle solutions.

The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists; and solutions for schools, including teletherapy platform, Televate, and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers.

In addition, it offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. Additionally, the company provides language services, vendor management systems, workforce optimization, and outsourced solutions.

The company offers its services under the brands, including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.

Stock analysis

AMN Healthcare Services Inc (AMN) currently trades at $36.19, while our model-based Fair Value estimate is $66.90, implying the stock looks roughly 46% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $56.88 per share, and 6 of the 9 models we run sit above the $36.19 price.

Bear case: the Multiples group reads lowest at $48.74, and 3 of the 9 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $37.67 (bear) to $100.54 (bull), the price of $36.19 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

AMN Healthcare Services Inc reported revenue of $2.7B in FY2025 versus $4.0B in FY2021, a compound −9.0%/yr. Reported net income was −$95.7M in FY2025.

Key figures

Market cap $1.8B Small · P/E ratio 13.5 · P/S ratio 0.52 · EPS (TTM) $2.68 · Net margin 3.1% · Return on equity 15.4% · Return on assets (EBIT) 9.3% (5-year average) · Operating margin 7.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 31 out of 100 (medium confidence).

What moves the price

The share trades about 26% below its 52-week high and 140% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at 85%, AMN screens cheaper than that median.

Fair Value models

Bear $37.67 Fair Value $66.90 Bull $100.54
Price $36.19 · Upside +84.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($2.29 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $56.23 $95.90 $153.45 76
Growth DCF $56.94 $91.40 $138.09 75
5Y EBITDA Exit $37.67 $66.90 $100.54 72
All 9 models by family
DCF Models
FCF DCF $56.23 $95.90 $153.45 76
Owner Earnings $7.53 $21.49 $41.75 69
5Y Revenue Exit $13.38 $21.02 $29.34 70
5Y EBITDA Exit $37.67 $66.90 $100.54 72
10Y Revenue Exit $28.78 $39.65 $52.10 65
10Y EBITDA Exit $43.98 $70.50 $104.93 65
Multiples
EV/EBITDA $31.59 $48.74 $65.88 66
Growth DCF
Growth DCF $56.94 $91.40 $138.09 75
Rev-Margin DCF $13.38 $22.35 $33.34 69

Open the full fair value analysis →

Quality Score breakdown

Overall quality 54/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 34
How much profit the company makes from its sales and capital
Quality Growth 48
Are margins and returns getting better?
Cashflow 58
Do the profits arrive as real cash?
Financial strength 36
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 72
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 81
Distance to the 52-week high, does not count
New shares 64
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director sold shares worth $114,369 and none bought.

  • SaleMark G FolettaDirector3,681 shares at $31.07$114,369Jun 15, 202610b5-1 plan

Plus 3 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−8.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−19.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.7%
Start year 2020 (pandemic). Over 10 years: +6.4% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
6.2% (2020) → 1.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes less growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−4.1%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
−9.6%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −6.3% a year for the price and −11.7% for the forecasts.
Forecast 2026 (sales)+22.9%
Forecast 2027 (sales)−20.4%
Projected 2028 (sales)−17.6%
Projected 2029 (sales)−14.8%
Projected 2030 (sales)−12.0%

Watch AMN, get fair value alerts →

Earlier news

News mood ⓘNews mood, the average tone of recent news (97 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.

Compare AMN Healthcare Services Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 233 stocks

Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 54 · Below median
Fair Value upside +84.9% · Top 25%
Profitability
Return on equity (12 months) 15.4% · Above median
Return on assets −4.6% · Bottom 25%
Net margin (12 months) 3.1% · Below median
Operating margin (12 months) 7.0% · Below median
Growth and dividend
Revenue growth (quarter YoY) 13.0% · Above median
Balance sheet
Debt / equity 1.20× · Highest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (12 months) 13.5× · Cheaper than median
P/B 2.86× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.52× · Cheapest 25%
Price / free cash flow (fiscal year) 7.9× · Cheapest 25%
EV/EBITDA 7.6× · Cheaper than median
PEG 1.71× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 34
FUTURE (revenue growth)65 · sector 30
PAST (return on equity)61 · sector 32
HEALTH (low debt)40 · sector 90
DIVIDEND (yield)0 · sector 39

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $23.40 $46.55 +99% vs AMN
Aier Eye Hospital Group 300015 ¥9.01 ¥10.88 +21% vs AMN
DaVita Inc DVA $191.35 $218.90 +14% vs AMN
HCA Healthcare, Inc HCA $494.99 $547.34 +11% vs AMN
Tenet Healthcare Corporation THC $283.33 $279.20 −1% vs AMN
Encompass Health Corporation EHC $137.54 $94.81 −31% vs AMN
IHH Healthcare Berhad 5225 7.70 MYR 5.23 MYR −32% vs AMN
Fresenius SE FRE €52.48 €34.77 −34% vs AMN
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,446 ₹5,234 −38% vs AMN
Dr. Sulaiman Al Habib Medical Services Group 4013 215.80 SAR 109.45 SAR −49% vs AMN

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

AMN Healthcare Services Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "AMN Healthcare Services Inc Fair Value". https://www.fairvalue-calculator.com/stock/AMN

Frequently asked questions

Is AMN Healthcare Services Inc (AMN) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $66.90 versus a price of $36.19, about +85% upside (undervalued).
What is the fair value of AMN?
Our model-based fair value for AMN Healthcare Services Inc is $66.90 (as of Nov 6, 2026), built from audited fundamentals. The current price: $36.19.
What is the quality score of AMN?
AMN Healthcare Services Inc has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for AMN Healthcare Services Inc (AMN)?
Our model-based price target is the fair value of $66.90 (as of Nov 6, 2026) from 9 valuation models. Cautious scenario $37.67, optimistic scenario $100.54. It is a calculation from audited fundamentals, not an analyst target.
What is the AMN Healthcare Services Inc stock forecast for 2026?
Our models put fair value at $66.90, about +85% upside versus a price of $36.19 (undervalued). Cautious scenario $37.67, optimistic scenario $100.54. The calculation is refreshed regularly with new filings.
What is the revenue of AMN Healthcare Services Inc (AMN)?
AMN Healthcare Services Inc reported trailing-twelve-month revenue of about $3.5B (latest available figure, as of Nov 6, 2026).
What growth is priced into AMN Healthcare Services Inc (AMN)?
For today's price to be fair in a discounted-cash-flow model, AMN Healthcare Services Inc would have to grow free cash flow by -4.1 % per year for five years (discount rate 9.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.7 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of AMN use?
Our models discount AMN Healthcare Services Inc at 9.8 %: a base by market capitalisation (small), damped by beta 0.45, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For AMN Healthcare Services Inc that is -4.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.8 %) and the same formula as our fair value.
How much growth has AMN Healthcare Services Inc (AMN) delivered so far?
Over the past 5 years revenue at AMN Healthcare Services Inc grew +2.7 % a year. The price currently implies free-cash-flow growth of -4.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of AMN Healthcare Services Inc (AMN) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into AMN Healthcare Services Inc (-4.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of AMN Healthcare Services Inc (AMN)?
The free-cash-flow yield on the price is 16.26 %: that much free cash flow AMN Healthcare Services Inc produces per unit of market value. When it exceeds the discount rate of our models (9.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of AMN Healthcare Services Inc (AMN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For AMN Healthcare Services Inc it is $66.90 per share (as of Nov 6, 2026), against a price of $36.19. It is the blended result of 9 valuation models in 3 families (DCF Models, Multiples, Growth DCF).
Is AMN Healthcare Services Inc stock overvalued or undervalued in 2026?
As of Nov 6, 2026, AMN trades below its calculated fair value: price $36.19, fair value $66.90, a gap of about +85% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AMN?
No. The price is what the market pays today ($36.19); the fair value is what the company's own numbers justify ($66.90). For AMN Healthcare Services Inc the two are $30.71 per share apart. That gap is exactly why we show both numbers side by side.
How much is AMN Healthcare Services Inc worth?
The market values AMN Healthcare Services Inc at about $1.8B (market capitalisation, as of Nov 6, 2026). Per share that is $36.19; our models calculate a fair value of $66.90 per share.
What do the bullish and bearish scenarios say about AMN?
Our models span a range for AMN Healthcare Services Inc: cautious scenario $37.67, base $66.90, optimistic $100.54 per share (as of Nov 6, 2026, price $36.19). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AMN?
AMN Healthcare Services Inc trades at a price-to-earnings ratio of 13.5 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $66.90 is built from several models across several years. Median P/E at fiscal year-end, 8 fiscal years (2016 to 2023), reported earnings: 18.2. Other multiples: PEG 1.7, P/B 2.9, P/S 0.5, EV/EBITDA 7.6.
What is the PEG ratio of AMN?
The PEG ratio of AMN Healthcare Services Inc is 1.71 (P/E divided by earnings growth, as of Nov 6, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of AMN Healthcare Services Inc (AMN)?
Balance-sheet figures for AMN Healthcare Services Inc (as of Nov 6, 2026): return on equity 15.4%, debt of 1.20 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is AMN from its 52-week high?
AMN Healthcare Services Inc trades at $36.19, about 26% below its 52-week high of $49.00 and 140% above the low of $15.10 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $66.90 is for.
Which stocks are comparable to AMN Healthcare Services Inc?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is AMN Healthcare Services Inc stock attractive at the current price?
The data as of Nov 6, 2026: price $36.19, calculated fair value $66.90 (+85%), Quality Score 54/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AMN calculated?
We run AMN Healthcare Services Inc through 9 models from 3 families: DCF Models, Multiples, Growth DCF. Every model gets the same audited fundamentals; the fair value of $66.90 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. AMN Healthcare Services Inc currently trades 46% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of AMN Healthcare Services Inc (AMN)?
The closing price on Nov 6, 2026 was $36.19. Our model-based fair value is $66.90, about +85% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with AMN Healthcare Services Inc right now?
The price is below even our cautious bear case ($37.67). The market is more pessimistic than our downside scenario. The model range is unusually wide ($37.67 to $100.54). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of AMN Healthcare Services Inc

How large is the market capitalisation of AMN Healthcare Services Inc (AMN)?
The market capitalisation of AMN Healthcare Services Inc is $1.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of AMN Healthcare Services Inc (AMN)?
The price-to-sales ratio of AMN Healthcare Services Inc is 0.52 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of AMN Healthcare Services Inc (AMN)?
Earnings per share at AMN Healthcare Services Inc are $2.68 (price ÷ EPS = P/E 13.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of AMN Healthcare Services Inc (AMN)?
The net margin of AMN Healthcare Services Inc is 3.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of AMN Healthcare Services Inc (AMN)?
The return on equity (ROE) of AMN Healthcare Services Inc is 15.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of AMN Healthcare Services Inc (AMN)?
On an EBIT basis the return on assets of AMN Healthcare Services Inc is 9.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of AMN Healthcare Services Inc (AMN)?
The operating margin of AMN Healthcare Services Inc is 7.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at AMN Healthcare Services Inc (AMN)?
Revenue at AMN Healthcare Services Inc is growing +13.0% versus a year earlier (3y avg −19.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at AMN Healthcare Services Inc (AMN)?
Earnings per share at AMN Healthcare Services Inc are growing +9.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does AMN Healthcare Services Inc (AMN) carry?
The net debt of AMN Healthcare Services Inc is $769M (fiscal year 2025, ≈ 3.3 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch AMN Healthcare Services Inc in the live analysis

One click puts AMN Healthcare Services Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.